Skip to main content

Next Generation Sequencing (NGS) for Rare Diseases Diagnosis - Volume II

Cover image for Research Topic "Next Generation Sequencing (NGS) for Rare Diseases Diagnosis - Volume II"
97kviews
Editorial10 July 2023
Editorial: Next generation sequencing (NGS) for rare diseases diagnosis ‐ Volume II

Next generation sequencing (NGS) has greatly facilitated the diagnosis of rare diseases. According to a 2013 statistic, 87% of Mendel's genetic disease-causing genes were discovered by NGS technology from 2007 to 2013 (McKusick 2007). To emphasize the significance of NGS and present high-quality research on prevention, diagnostics, and treatment, we previously launched a special issue in Frontiers in Genetics. Due to popular demand, the Research Topics were extended as Volume II. A totally of 16 articles were published in this volume, comprising 16 articles covering various topics such as preimplantation and prenatal diagnosis, case reports of rare diseases, multiple case summaries, and hematological tumors.

Giving birth to a healthy baby (or babies) is an exceptional gift for families with genetic diseases. In the case of a male proband from unrelated healthy parents, several complications arose during the first pregnancy, including extensive neurogenic damage, developmental delay, and an enlarged heart (Shi and Ye 2023). To determine the genetic pathogenic variant, karyotype analysis, Fluorescence in situ hybridization (FISH), whole exome sequencing (WES), and copy number variants (CNV) sequencing were conducted. WES revealed heterozygous variants in DUOX2 (c.1588A>T (p.K530X), c.2654G>T (p.R885L)), respectively inherited from the mother and father. Although the karyotype analysis was normal, CNV sequencing showed a de novo Xq28-q28 duplication (5.59 Mb × 2) and 18q22.2-q23 deletion (9.85 Mb × 1) in the proband. FISH revealed that the mother was a carrier of a reciprocal translocation (RecT) between ChrX and Chr18 [t (X; 18) (q28; q22.2)]. To identify embryos free of pathogenic variants, preimplantation genetic testing was conducted. This was followed by amniocentesis at gestational week 20, which confirmed the fetal genetic makeup. Ultimately, a healthy infant was delivered. This case report underscores the importance of using NGS in preimplantation prenatal diagnosis. Furthermore, the study highlights the need for a multi-technical approach that includes karyotype analysis, FISH, and linkage analysis in reproductive medicine.Yu et al. reported a case of fetal tetrasomy 9p, which was initially identified by non-invasive prenatal testing (NIPT) (Yu et al. 2022). The 37-year-old pregnant woman was healthy and had undergone NIPT due to advanced maternal age. At 12 weeks of gestation, an ultrasound screening revealed normal nuchal translucency (NT) and nasal bone. Unfortunately, at 15 weeks of gestation, the NIPT indicated a duplication at 9p24.3p11.2. The result was validated through amniocentesis, karyotyping, chromosome microarray (CMA), and FISH. Based on the opinions of the pregnant woman and her husband, the pregnancy was terminated. It is recommended that NIPT should be carried out in cases of advanced maternal age to rule out fetal genetic variations, even in the absence of fetal abnormalities revealed by ultrasound examination.Norrie disease (ND) is an X-linked recessive disorder that can result in blindness in early postnatal stages due to retinal detachment (Meire et al. 1998). A 29-year-old pregnant woman gave birth to a son who was born with congenital bilateral blindness, but showed no signs of cognitive impairment or deafness (Li et al. 2022) The Ehlers-Danlos syndromes (EDS) are a group of connective tissue diseases that can be inherited. A specific subtype of EDS, known as Musculocontractural Ehlers-Danlos syndrome (mcEDS), can be caused by mutations in the carbohydrate sulfotransferase 14 (CHST14) or dermatan sulfate epimerase genes (Malfait et al. 2010). In this case, a 34-year-old woman who was 22 weeks pregnant had an ultrasound that showed her fetus had adduction flexion in the feet (Zhou, Du, et al. 2022). She then underwent prenatal testing, which included WES, CNV sequencing, and amniotic fluid cell karyotype analysis. Two potential genetic causes for mcEDS were identified as variants in the CHST14 gene (NM_130468.3 c.958C>T (p.Arg320*) & NM_130468.3 c.896A>G (p.Tyr299Cys)). This study has expanded our understanding of the genetic causes of mcEDS.

Before the advent of NGS, due to limitations in research methods, many pathogenic genes and sites of rare diseases were not fully studied. This resulted in a number of extremely rare diseases with only dozens or even fewer cases reported worldwide. In this volume, three extremely rare case reports were published. One case involved a healthy, non-consanguineous Chinese couple who gave birth to a full-term infant girl (Chen et al. 2022). Unfortunately, the baby died at a few months of age due The Cdc42 molecule is a small GTPase that belongs to the Rho GTPase family and plays multiple important physiological functions in regulating the cell cycle. The heterozygous c.191A>G (p.Tyr64Cys) variant is reported as the pathogenic molecular etiology of Takenouchi-Kosaki syndrome (TKS). TKS is a range of phenotypic syndromes characterized by psychomotor development, dysmorphic facial features, and hematologic or lymphatic defects (Martinelli et al. 2018). In a male infant, a genetic syndrome was suspected due to facial dysmorphism, low-set ears, axial hypotonia with peripheral spasticity, camptodactyly, and cutaneous syndactyly of toes (Szczawińska-Popłonyk A et al. 2023). WES revealed the c.191A>G; p.Tyr64Cys (NM_001791.4) variant in the CDC42 gene, which was later confirmed through Sanger sequencing. While this study did not identify novel genetic sites, it does expand the clinical spectrum of TKS.

With the wide application of NGS, an increasing number of relationships between pathogenic genes and the phenotypes of monogenic genetic diseases have been established. Additionally, the mutation sites of Mendelian disease-causing genes have been widely reported. It is well-documented that mutations in the ATP7B gene could lead to an autosomal recessive disease called Wilson's disease (WD). In this volume, 39 and 30 genetically diagnosed WD cases were respectively studied by Wang et al. andZhou et al (Wang et al. 2023, Zhou, Zhang, et al. 2022). The participants in Wang's study were from Yunnan province in China, including seven different ethnic groups. Homozygous mutation frequency is higher, whereas protein-truncating variant (PTV) is less frequent in ethnic minorities compared with the Han population. Zhou et al. found that the frequency of p.R778L and p.I1148T is relatively high. They suggested that elevated alanine transaminase (ALT), decreased ceruloplasmin level, and increased 24-h urinary copper level should be considered as three important indices for rapid diagnosis.Autism spectrum disorder (ASD) is a cluster of common neurological developmental symptoms in the pediatric population. In this study, Zhang et al. recruited 354 ASD candidates and investigated the genetic etiology using WGS and RNA sequencing (Zhang et al. 2023). Pathogenic variants including single nucleotide variations (SNV), CNV, and structural variations (SV) were investigated. They found that ASD affected children had a relatively low frequency of rare CNV and SNV variants. The total positive rate (5.3%) was relatively lower than in other studies, and the authors attributed this to the mutation characteristics they focused on. It is worth noting that the authors used RNA sequencing and RT-PCR to validate the variants.Therefore, the false positive rate of mutations will be reduced.Variants in the LMNA gene can give rise to a range of clinical manifestations called laminopathies. To explore the genetic basis of LMNA-related muscular dystrophies, Cesar and colleagues enrolled 26 patients from different parts of the world and sequenced 105 genes using a targeted approach (Cesar et al. 2023). They identified that the most severe phenotypes resulted from the coexistence of a rare damaging variant in LMNA and another damaging variant in a gene involved in NMD.The authors highlighted the marked genetic heterogeneity of laminopathies and advocated for comprehensive genetic testing of both LMNA and other genes linked to muscle disorders to reveal potential causal mechanisms.Fabry disease (FD) arises from variants in the X chromosome-located GLA gene, which encodes alpha-galactosidase A (α-Gal A). Abnormal expression or function in α-Gal A activity can cause the buildup of trihexosaccharide sphingolipid alcohol (GL-3) and its derivative, deacetyl GL-3 (Lyso-GL-3). The clinical manifestations of FD are highly heterogeneous. Li et al. retrospectively analyzed ten patients who visited their hospital and were diagnosed with FD (Li et al. 2023). They provided a detailed description of the patients' clinical manifestations, laboratory and auxiliary examinations, FD-specific indexes and GLA genetic testing, pedigree screening, and treatment. The authors emphasized that it is critical for doctors to understand the clinical symptoms of FD and actively screen for early detection and diagnosis of the disease.

The incidence of tumors in children is generally low. However, acute lymphoblastic leukemia (ALL) is often observed in this population, which is highly correlated with altered lymphoid precursor hyperplasia. Furthermore, IKZF1 variants are frequently observed in children diagnosed with ALL. Zhang et al. conducted a study analyzing the clinical and genetic features of 200 B-cell ALL pediatric patients by utilizing MLPA and targeted NGS methodologies (Zhang et al. 2022). Their results indicate that IKZF1 variants were identified in 22 patients and there was a significant association between IKZF1 variants and higher WBC counts. Moreover, the study revealed that patients with IKZF1 mutations had decreased sensitivity to glucocorticoid induction and higher levels of minimal residual disease compared with patients with IKZF1 wildtype. This research sheds light on the association between genetic mutations and clinical features, providing new perspectives for targeted therapy in ALL.

5,086 views

4 citations

Genetic variations in the DYNC2H1 gene causing SRTD3 (short-rib thoracic dysplasia 3 with or without polydactyly)
ORIGINAL RESEARCH
6 April 2023
Genetic variations in the DYNC2H1 gene causing SRTD3 (short-rib thoracic dysplasia 3 with or without polydactyly)
Wenqi Chen, 7 more and Qing Guo
Background and aims: Short-rib thoracic dysplasia 3 with or without polydactyly (SRTD3) represents a type of severe fetal skeletal dysplasia (SD) characterized by shortened limbs, narrow thorax with or without polydactyly, which is caused by the homozygous or compound heterozygous mutations in the DYNC2H1 gene. SRTD3 is a recessive disorder, identification of the responsible genetic variation would be beneficial to an accurate prenatal diagnosis and well-grounded counseling for the affected families. Materials and methods: Two families having experienced recurrent fetal SDs were recruited and submitted to a multiplatform genetic investigation. Whole-exome sequencing (WES) was performed with samples collected from the probands. Sanger sequencing and fluorescent quantitative PCR (qPCR) were conducted as validation assays for suspected variations. Results: WES identified two compound heterozygous variations in the DYNC2H1(NM_001080463.2) gene, namely c.2386C>T(p.Arg796Trp) and c.7289T>C(p.Ile2430Thr) for one; and exon(64-83)del and c.8190G>T(p.Leu2730Phe) for the other, respectively. One variant in them, exon(64-83)del, was novelly identified. Conclusion: The study detected two compound heterozygous variation in DYNC2H1 including one novel deletion: exon(64-83)del. Our findings clarified the cause of fetal skeletal dysplasia in the subject families, provided guidance for their future pregnancies, and highlighted the value of WES in diagnosis of skeletal dysplasia with unclear prenatal indications.

6,112 views

6 citations

CASE REPORT
6 June 2023
The clinical phenotype with gastrostomy and abdominal wall infection in a pediatric patient with Takenouchi-Kosaki syndrome due to a heterozygous c.191A > G (p.Tyr64Cys) variant in CDC42: a case report
Aleksandra Szczawińska-Popłonyk, 6 more and Jarosław Walkowiak

3,421 views

9 citations

ORIGINAL RESEARCH
24 March 2023
LMNA-related muscular dystrophy: Identification of variants in alternative genes and personalized clinical translation
Sergi Cesar, 24 more and Oscar Campuzano
Background: Laminopathies are caused by rare alterations in LMNA, leading to a wide clinical spectrum. Though muscular dystrophy begins at early ages, disease progression is different in each patient. We investigated variability in laminopathy phenotypes by performing a targeted genetic analysis of patients diagnosed with LMNA-related muscular dystrophy to identify rare variants in alternative genes, thereby explaining phenotypic differences. Methods: We analyzed 105 genes associated with muscular diseases by targeted sequencing in 26 pediatric patients of different countries, diagnosed with any LMNA-related muscular dystrophy. Family members were also clinically assessed and genetically analyzed. Results: All patients carried a pathogenic rare variant in LMNA. Clinical diagnoses included Emery-Dreifuss muscular dystrophy (EDMD, 13 patients), LMNA-related congenital muscular dystrophy (L-CMD, 11 patients), and limb-girdle muscular dystrophy 1B (LGMD1B, 2 patients). In 9 patients, 10 additional rare genetic variants were identified in 8 genes other than LMNA. Genotype-phenotype correlation showed additional deleterious rare variants in five of the nine patients (3 L-CMD and 2 EDMD) with severe phenotypes. Conclusions: Analysis f known genes related to muscular diseases in close correlation with personalized clinical assessments may help identify additional rare variants of LMNA potentially associated with early onset or most severe disease progression.
LMNA-related muscular dystrophy: Identification of variants in alternative genes and personalized clinical translation

7,999 views

16 citations

Genetic diagnostic yields of 354 Chinese ASD children with rare mutations by a pipeline of genomic tests
Purpose: To establish an effective genomic diagnosis pipeline for children with autism spectrum disorder (ASD) for its genetic etiology and intervention. Methods: A cohort of 354 ASD patients were obtained from Beijing Children's Hospital, Capital Medical University. Peripheral blood samples of the patients were collected for whole genome sequencing (WGS) and RNA sequencing (RNAseq). Sequencing data analyses were performed for mining the single nucleotide variation (SNV), copy number variation (CNV) and structural variation (SV). Sanger sequencing and quantitative PCR were used to verify the positive results. Results: Among 354 patients, 9 cases with pathogenic/likely pathogenic CNV and 10 cases with pathogenic/likely pathogenic SNVs were detected, with a total positive rate of 5.3%. Among these 9 CNV cases, 5 were de novo and 4 were inherited. Among the 10 de novo SNVs, 7 were previously unreported. The pathological de novo mutations accounts for 4.2% in our cohort. Conclusion: Rare mutations of CNVs and SNVs account for a relatively small proportion of ASD children, which can be easily detected by a genomic testing pipeline of combined WGS and RNAseq. This is important for early etiological diagnosis and precise management of ASD with rare mutations.

5,347 views

7 citations

CASE REPORT
21 March 2023
Case report: Gene mutation analysis and skin imaging of isolated café-au-lait macules
Zhenyu Zhong, 9 more and Min Gao

6,232 views

2 citations

ORIGINAL RESEARCH
20 March 2023
Clinical and genetic characterization of pediatric patients with Wilson’s disease from Yunnan province where ethnic minorities gather
Yanjun Wang, 9 more and Shufang Xiao

3,823 views

9 citations

CASE REPORT
24 February 2023
Case report: Expansion of phenotypic and genotypic data in TENM3-related syndrome: Report of two cases
Fen Lu, 5 more and Xiaoke Zhao

5,915 views

6 citations

Clinical features and enzyme replacement therapy in 10 children with Fabry disease
ORIGINAL RESEARCH
3 February 2023
Clinical features and enzyme replacement therapy in 10 children with Fabry disease
Qian Li, 7 more and Shuzhen Sun

4,067 views

11 citations

ORIGINAL RESEARCH
12 August 2022
Next-generation sequencing reveals a case of Norrie disease in a child with bilateral ocular malformation
Haijun Li, 6 more and Xingsheng Dong

3,416 views

4 citations

ORIGINAL RESEARCH
28 April 2022
Genetic Landscape of Nephropathic Cystinosis in Russian Children
K. V. Savostyanov, 11 more and A. N. Tsygin

4,164 views

7 citations

ORIGINAL RESEARCH
28 March 2022
Clinical and Genetic Characteristics of IKZF1 Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia
Jingying Zhang, 13 more and Diying Shen
Clinical and Genetic Characteristics of IKZF1 Mutation in Chinese Children With B-Cell Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a malignancy associated with altered lymphoid precursor hyperplasia and accompanied with different genetic mutations. Few studies have been reported on the association between gene mutations and clinical features of IKZF1 mutation in children with B-cell ALL (B-ALL). We investigated clinical and genetic characteristics in 200 newly diagnosed pediatric B-ALL through multiplex ligation-dependent probe amplification (MLPA) and targeted next-generation sequencing (NGS) method. We found that IKZF1 mutations, including large segment deletions, small insertions or deletions (InDels) and single nucleotide variations (SNVs), were detected in 22 patients with a positive mutation rate of 11.0%. IKZF1 mutation was significantly associated with higher WBC count (19.38×109/L vs. 5.80×109/L, P = 0.002). Compared with IKZF1 wild-type cases, a higher frequency of IL7R gene mutation was discovered in IKZF1 mutant cases (9.1% vs. 0.0%, P = 0.012). Patients with IKZF1 mutation were less sensitive to glucocorticoid induction than patients without IKZF1 mutation (54.5% vs. 9.0%, P < 0.001). On the 15th day of induction, minimal residual disease (MRD) >10-3 level were higher in IKZF1 mutant patients than wild-type patients (45.5% vs. 14.0%, P = 0.018). In conclusion, our study reveals the association between genetic mutations and clinical features in Chinese children with B-ALL, which might contribute to molecular classification, risk stratification and prognosis evaluation, and provide new ideas for targeted therapy in ALL.

5,781 views

5 citations

CASE REPORT
8 April 2022
Case Report: A Novel Mutation Identified in CHST14 Gene in a Fetus With Structural Abnormalities
Yuan-Yuan Zhou, 6 more and Ying Zhong

3,077 views

4 citations